Navigation Links
Dohmen to Sell Restat, its Pharmacy Benefit Manager (PBM) Division to Catamaran
Date:8/1/2013

Milwaukee, WI (PRWEB) August 01, 2013

Catamaran, the industry’s fastest-growing pharmacy benefit manager, will buy Milwaukee, WI-based Restat, from its parent company Dohmen, for $409.5 million in a transaction expected to close in the fourth quarter of 2013, the companies announced today.

Catamaran CEO Mark Thierer said the addition of Restat will create immediate value for clients and members of both organizations. “As one of the largest privately held pharmacy benefit managers, Restat’s core business is perfectly aligned with Catamaran’s. We have a full suite of services that will complement the strengths of Restat to create a unique go-to-market PBM.”

Dohmen CEO Cynthia (Dohmen) LaConte agrees, “Dohmen’s been committed to creating efficiencies in healthcare supply for over 155 years, so it was important for us to partner with a company that could lower prescription drug costs without compromising care. Catamaran has a unique track record of achieving the right balance of scale and service. Joining Catamaran will create an even stronger marketplace offering in cost, clinical capability and customer service.”

LaConte said the sale of Restat is part of Dohmen’s strategic plan to grow and strengthen its life science service offering. “We’ve decided to exit the pharmacy benefit management business so we can focus exclusively on our life science clients. Dohmen has a long history of anticipating transformative change and building better business models to meet it, and our industry is facing a significant paradigm shift from volume to value. We think we’re uniquely positioned to help drug, device and personalized medicine companies make this transition.”

The agreement to sell Restat, was signed by Catamaran and Dohmen on July 31, 2013, and is set to close in the fourth quarter of 2013.

About Dohmen
Founded in 1858, Dohmen is a life science services company dedicated to creating a safe
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Dohmen’s BioSoteria Calls for Abstracts for its Seventh Annual Pacific Drug Safety Summit (PDSS)
2. Pharmacy Robots Linked to Bacterial Contamination of Drugs
3. A Void In The Independent Pharmacy Industry Leads to Independent Rx Consulting, Powered by OurHelix
4. Second Compounding Pharmacy Shut Down in Massachusetts
5. Company With Links to Meningitis-Linked Pharmacy Recalls All Products
6. Company With Ties to Meningitis-Linked Pharmacy Recalls All Products
7. Owner of Meningitis-Linked Pharmacy Declines to Testify Before Congress
8. Women’s Excellence in Bladder Control Partners with University Compounding Pharmacy in Troy, MI to Help Women with Chronic Pelvic Pain Conditions
9. Pharmacy researcher finds most popular weight-loss drug strongly alters other drug therapies
10. ShopPharmacyCounter.com Unveils PhenObestin 37.5 to Offset Obesity Effectively
11. FDA, States Weigh Pharmacy Regulation in Wake of Meningitis Outbreak
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2015)... ... August 30, 2015 , ... Nutritional ... from Administrative assistant to Executive Assistant to CEO Mitch Gould for Nutritional Products ... focused on your goals. Kathleen graduated from Florida State University with a ...
(Date:8/29/2015)... ... ... On September 30, 2015, the Career and Transfer Center (CTC) at Estrella ... Colleges , will be hosting a Job Expo to provide a professional, open venue ... Expo has expanded to much more than just a typical job and career fair. ...
(Date:8/29/2015)... ... August 29, 2015 , ... "I have been ... Place, N.Y. "I specialize in manual therapy, and my invention will provide headache ... used for additional muscle dysfunction throughout the body." , They developed THE RELIEVER ...
(Date:8/29/2015)... ... August 29, 2015 , ... Dr. Tim Novelli, DC., Founder and President of ... increase acceptance of the chiropractic field in the military. All too often VA hospitals ... Chiropractic was made available to the VA program over a decade ago, the reality ...
(Date:8/29/2015)... CA (PRWEB) , ... August 29, 2015 , ... ProDrop ... X . Each preset contains 15 seconds of unique footage that users can shrink ... rise, fall, zoom, attract and more. Users can customize color, brightness, scale, speed, range, ...
Breaking Medicine News(10 mins):Health News:NPI Appoints New Executive Assistant To CEO 2Health News:Estrella Mountain Community College Expo Offers ‘One-Stop’ for Employers and Students Seeking Internships, Jobs, Careers and Service Learning Opportunities 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:The Patriot Project brings Chiropractic Care to the Armed Forces and their Families - Rapid Release Technology Joins the Effort to Recruit more Doctors to Pledge 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2
... the first time, results on the impact of gaming devices ... at the EULAR 2011 Annual Congress. Data comparing two schools ... of pain following long term use of gaming devices and ... joint health. , The study, involving 257 students, highlights that ...
... , WEDNESDAY, May 25 (HealthDay News) --,The ability of ... level of commitment in their romantic relationships can be traced ... finds. Researchers asked 78 people aged 20 or 21 ... their relationship. The researchers already had data on the ...
... By Amanda Gardner HealthDay Reporter , TUESDAY, ... doctors a community has, especially ones who are actually ... are, a new Dartmouth study suggests. Those ... death rate among local elders, the researchers found. ...
... Goodwin HealthDay Reporter , TUESDAY, May 24 (HealthDay ... pitched sounds when underwater than they can while on terra ... with their bones rather than through the normal pathways of ... humans hear above or below water differs; that difference means ...
... Clinical trials for a new bladder cancer therapy show ... the breakthrough using the drug Urocidin follows thirty years ... am optimistic about the results of the trial," says ... at Queen,s University and director of the Queen,s University ...
... News) -- Losing weight may not be required to lower ... Rather, the study found, small dietary changes can make a ... among blacks. For the study, published online May 18 ... researchers put 69 overweight people at risk for diabetes on ...
Cached Medicine News:Health News:Children experience wrist and finger pain when using gaming devices and mobile phones over time 2Health News:Capacity for Commitment May Start in Early Childhood 2Health News:More Primary Care Docs in a Community Equals Healthier Seniors 2Health News:More Primary Care Docs in a Community Equals Healthier Seniors 3Health News:Underwater, Humans Hear Through Their Bones 2Health News:Underwater, Humans Hear Through Their Bones 3Health News:New made-in-Canada therapy for bladder cancer shows promising results 2Health News:Simply Eating Less Fat May Cut Diabetes Risk 2
(Date:8/28/2015)... , Aug. 28, 2015  Delays in ... projects can slow down the decision-making process, resulting ... therefore, absolutely critical for biopharmaceutical companies to develop ... approval process for quicker and more meaningful insights. ... Best Practices, LLC, nearly three-quarters of benchmarked study ...
(Date:8/28/2015)... 2015 Research and ... of the "12th Annual Report and Survey ... to their offering. The 2015 12th ... and Production is the most recent study of ... projected future capacity and production. The report contains ...
(Date:8/28/2015)... 28, 2015 Research ... of the "Investigation Report on China,s Insulin ... Developed by Novo Nordisk, insulin aspart ... important drug for the treatment of diabetes. Compared ... acting insulin analog, starts working fast and reports ...
Breaking Medicine Technology:Expediting the Pharmaceutical Market Research Process for Faster Insights 212th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2
... issued today a shareholders, letter discussing the results of its fiscal ... Dear Imagenetix shareholder - Following ... we commence the new fiscal year, I would like to address ...   Over the past few years our primary strategy ...
... July 12, 2011 Arena Pharmaceuticals, Inc. (NASDAQ: ... 1 clinical trial of APD811, an orally bioavailable agonist ... treatment of pulmonary arterial hypertension, or PAH. ... tolerability and pharmacokinetics of 0.03 mg, 0.05 mg, 0.1 ...
Cached Medicine Technology:Imagenetix, Inc. Discusses March 31, 2011 Fiscal Year End Results and Future Focus 2Imagenetix, Inc. Discusses March 31, 2011 Fiscal Year End Results and Future Focus 3Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension 2Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension 3Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension 4
... Quality Analysis System) developed by Pablo Artal, ... first diagnostic tool for ophthalmology that provides ... system. Never before has an ophthalmologist had ... quality of vision. , ,OQAS works by ...
... -Chagas is an in-vitro diagnostic test ... to Trypanosoma cruzi in human serum/plasma. ... particle-agglutination assay using gelatin particles coated ... coated gelatin particles are agglutinated in ...
Inquire...
Elisa test for qualitative detection of Total antibodies to Trypanosoma Cruzi in human serum or plasma....
Medicine Products: